BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

By Deborah W Knapp

Comparative Oncology Program, Purdue University, West Lafayette, IN

View Presentation

Additional materials available (3)

Licensed under General Performance Usage.

Published on

Abstract

Guest lecturer: Deborah Knapp.

Cite this work

Researchers should cite this work as follows:

  • Deborah W Knapp (2011), "BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention," https://nanohub.org/resources/12622.

    BibTex | EndNote

Time

Location

1083 BME, Purdue University, West Lafayette, IN

Tags

BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention
  • BME 695L Engineering Nanomedical Systems October 20, 2011 Copyright, 2011 – Deborah W. Knapp 1. BME 695L Engineering Nanomedic… 0
    00:00/00:00
  • Cancer Research – the Flow of Information Translation – 2. Cancer Research – the Flow o… 124.59125792459126
    00:00/00:00
  • In Vivo Studies, i.e. Animal Studies 3. In Vivo Studies, i.e. Animal S… 143.677010343677
    00:00/00:00
  • In Vivo Studies of New Treatment Agents 4. In Vivo Studies of New Treatme… 168.06806806806807
    00:00/00:00
  • In Vivo Studies – New Treatment Agent Studies 5. In Vivo Studies – New Treatm… 227.46079412746082
    00:00/00:00
  • Types of Animals for ADME and Toxicity Studies 6. Types of Animals for ADME and … 250.71738405071739
    00:00/00:00
  • Is the Animal Work Really Necessary? Student Input………… 7. Is the Animal Work Really Nece… 278.77877877877881
    00:00/00:00
  • Is the Animal Work Really Necessary? 8. Is the Animal Work Really Nece… 345.77911244577911
    00:00/00:00
  • Efficacy Studies: Need Tumor-Bearing Animals 9. Efficacy Studies: Need Tumor-B… 523.99065732399072
    00:00/00:00
  • Types of 10. Types of "Animal Models" of Hu… 557.09042375709043
    00:00/00:00
  • Chemically-Induced Colon Tumors in a Rat 11. Chemically-Induced Colon Tumor… 607.67434100767434
    00:00/00:00
  • Transgenic Models 12. Transgenic Models 623.79045712379047
    00:00/00:00
  • Immunocompromised Animals With 13. Immunocompromised Animals With… 636.00266933600267
    00:00/00:00
  • Syngeneic Mouse Models 14. Syngeneic Mouse Models 664.597931264598
    00:00/00:00
  • IVIS SPECTRUM 15. IVIS SPECTRUM 678.37837837837844
    00:00/00:00
  • Imaging NPs After Tail-vein Injection 16. Imaging NPs After Tail-vein In… 693.76042709376043
    00:00/00:00
  • Tracking NPs Over Time (ex-vivo images) 17. Tracking NPs Over Time (ex-viv… 785.38538538538546
    00:00/00:00
  • Are These Animal Models Good Enough and Complete Enough? 18. Are These Animal Models Good E… 814.04738071404745
    00:00/00:00
  • Naturally-Occurring Canine Cancer 19. Naturally-Occurring Canine Can… 951.45145145145148
    00:00/00:00
  • Translational Cancer Research 20. Translational Cancer Research 1018.7854521187855
    00:00/00:00
  • Translational Cancer Research 21. Translational Cancer Research 1038.1715048381716
    00:00/00:00
  • Why Study Pet Dogs With Naturally-Occurring Cancer? 22. Why Study Pet Dogs With Natura… 1044.7113780447114
    00:00/00:00
  • Why Study Pet Dogs With Naturally-Occurring Cancer? 23. Why Study Pet Dogs With Natura… 1087.8211544878211
    00:00/00:00
  • Why Study Pet Dogs With Naturally-Occurring Cancer? 24. Why Study Pet Dogs With Natura… 1259.7931264597933
    00:00/00:00
  • Example: Urinary Bladder Cancer 25. Example: Urinary Bladder Cance… 1298.8655321988656
    00:00/00:00
  • Stages of Urinary Bladder Cancer 26. Stages of Urinary Bladder Canc… 1371.7050383717051
    00:00/00:00
  • Urinary Bladder Cancer 27. Urinary Bladder Cancer 1405.4387721054388
    00:00/00:00
  • Urinary Bladder Cancer Invasive TCC: 28. Urinary Bladder Cancer Invasiv… 1477.2105438772105
    00:00/00:00
  • Urinary Bladder Cancer – Transitional Cell Carcinoma 29. Urinary Bladder Cancer – Tra… 1518.0513847180514
    00:00/00:00
  • Bladder Cancer Staging Real Time NIRF Imaging to Map Lymph Node Drainage 30. Bladder Cancer Staging Real Ti… 1635.1017684351018
    00:00/00:00
  • Bladder Cancer is Like Many Other Cancers; Progress is Greatly Needed 31. Bladder Cancer is Like Many Ot… 1792.9596262929597
    00:00/00:00
  • Clinical Challenges in InvTCC How Can We Apply Nanomedicine? 32. Clinical Challenges in InvTCC … 1898.8321654988322
    00:00/00:00
  • What Are the Greatest Challenges Remaining in Designing and Testing Nanoparticles for Cancer? 33. What Are the Greatest Challeng… 2098.5318651985322
    00:00/00:00
  • Challenges in Nanoparticle Treatment of Cancer 34. Challenges in Nanoparticle Tre… 2110.744077410744
    00:00/00:00
  • Challenges in Nanoparticle Treatment of Cancer 35. Challenges in Nanoparticle Tre… 2178.9122455789125
    00:00/00:00
  • Challenges in Nanoparticle Treatment of Cancer 36. Challenges in Nanoparticle Tre… 2226.8268268268271
    00:00/00:00
  • How Can you Find A Veterinary Collaborator? 37. How Can you Find A Veterinary … 2266.3663663663665
    00:00/00:00
  • Bladder Cancer Related Research: Investigators, Staff, and Collaborators 38. Bladder Cancer Related Researc… 2344.377711044378
    00:00/00:00
  • Questions? 39. Questions? 2363.6970303636972
    00:00/00:00